Beta Blocker Selection for Cardiovascular Indications

Introduction to Beta Blockers

• Beta blockers can be classified as cardioselective (e.g., metoprolol) or non-selective (e.g., nadolol), affecting both beta-1 and beta-2 receptors, according to the American Heart Association 1, 2

Hypertension Management

• The American College of Cardiology recommends metoprolol as a first-line beta blocker for hypertension, with a dosage of 50-200 mg daily 3, 2, 4, 5
• Other beta blockers, such as atenolol, bisoprolol, and betaxolol, are also effective for hypertension, with varying dosages 4, 5, 6, 7

Atrial Fibrillation Treatment

• Both metoprolol and nadolol are effective for rate control in atrial fibrillation, as stated by the American Heart Association, with nadolol and atenolol found to be the most efficacious beta blockers tested in AF management studies 3, 2
• The 2014 AHA/ACC/HRS guidelines list both metoprolol and nadolol as options for rate control in atrial fibrillation 3

Heart Failure Management

• Metoprolol succinate is preferred for heart failure with reduced ejection fraction, as recommended by the American College of Cardiology, due to its established mortality benefit 8, 4, 5
• Carvedilol and bisoprolol are also preferred for heart failure, providing both alpha and beta blockade, with dosages of 12.5-50 mg twice daily (or 20-80 mg once daily for phosphate) and 2.5-10 mg once daily, respectively 4, 5

Respiratory Considerations

• Metoprolol's cardioselectivity makes it safer in patients with respiratory conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, as stated by the American Thoracic Society 9
• Non-selective beta blockers like nadolol should be avoided in patients with bronchospastic disease, according to the American Academy of Allergy, Asthma, and Immunology 2
• Betaxolol is a cardioselective option preferred in patients with bronchospastic airway disease requiring beta blockade, with a dosage of 5-20 mg once daily 4

Special Populations

• For patients with certain arrhythmias, such as Catecholaminergic Polymorphic Ventricular Tachycardia, some experts prefer nadolol, but other beta blockers are effective 10
• For patients with Long QT Syndrome, propranolol, atenolol, and nadolol are preferred, while metoprolol appears less effective 10
• For patients with portal hypertension, nadolol is specifically recommended for patients with large esophageal varices, as stated by the American Association for the Study of Liver Diseases 11

Dosage and Administration

• The following beta blockers have established dosages:

Switching Between Beta Blockers

• When switching between metoprolol and nadolol, overlap therapy briefly to prevent withdrawal effects, and monitor blood pressure, heart rate, and disease-specific symptoms closely, as recommended by the American College of Cardiology 12
• Avoid abrupt discontinuation of nadolol before starting alternative therapy, as this can trigger dangerous cardiovascular events, and ensure therapeutic equivalence when switching between different beta blockers 12
• Be aware of potential interactions with other medications, particularly with non-dihydropyridine calcium channel blockers like diltiazem and verapamil 4